{
  "main_header": {
    "sid": 849091,
    "name": "Archit Organosys",
    "stock_name": "Archit Organosys",
    "full_name": "Archit Organosys Ltd",
    "name_url": "stocks-analysis/archit-organosys",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "40.50",
    "chg": -0.42,
    "chgp": "-1.03%",
    "dir": -1,
    "prev_price": "40.92",
    "mcapval": "82.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524640,
    "symbol": "",
    "ind_name": "Chemicals",
    "ind_code": 11,
    "isin": "INE078I01011",
    "curr_date": "Apr 11, 12:51 PM",
    "curr_time": "22:45 PM",
    "bse_nse_vol": "1.35 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/archit-organosys-849091-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Archit Organosys Adjusts Valuation Amid Mixed Financial Performance and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/archit-organosys-stock-upgraded-to-sell-amid-mixed-performance-and-declining-profits-1671175",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/ArchitOrganosys_mojoScore_862102.png",
        "date": "2025-04-02 08:11:59",
        "description": "Archit Organosys, a microcap chemicals company, has recently adjusted its evaluation, reflecting changes in financial metrics and market position. Key indicators show a high price-to-earnings ratio and a moderate sales growth rate, while technical performance presents mixed signals, indicating both challenges and opportunities in the current market landscape."
      },
      {
        "title": "Archit Organosys Experiences Valuation Grade Change Amidst Competitive Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/archit-organosys-changes-valuation-grade-from-fair-to-attractive-amid-stock-price-decline-1575519",
        "imagepath": "",
        "date": "2025-03-25 08:00:47",
        "description": "Archit Organosys, a microcap player in the chemicals industry, has recently undergone a valuation adjustment, reflecting a shift in its financial standing. The company's current price is at 39.20, with a previous close of 40.09. Over the past year, Archit has experienced a stock return of 1.06%, contrasting with a 7.07% return from the Sensex, indicating a lag in performance relative to the broader market.\n\nKey financial metrics reveal a PE ratio of 80.44 and an EV to EBITDA ratio of 16.32, which positions the company within a competitive landscape. Notably, Archit Organosys has a low PEG ratio of 0.00, suggesting a unique valuation perspective compared to its peers. In comparison, companies like Shivalik Rasayan and Indo Amines exhibit varying valuation metrics, with Shivalik showing a PE ratio of 61.17 and Indo Amines at 16.52.\n\nDespite the recent valuation adjustment, Archit’s performance over a five-yea..."
      },
      {
        "title": "Archit Organosys Adjusts Valuation Amidst Mixed Financial Performance and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/archit-organosys-downgraded-to-strong-sell-amid-weak-financial-performance-and-growth-concerns-1423431",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ArchitOrganosys_mojoScore_682524.png",
        "date": "2025-03-18 08:07:45",
        "description": "Archit Organosys, a microcap chemicals company, has recently adjusted its evaluation following a positive Q3 FY24-25 performance, reporting a profit after tax of Rs 2.03 crore. However, challenges remain in long-term growth and financial strength, with modest sales growth and bearish technical indicators."
      },
      {
        "title": "Archit Organosys Reports Profit Growth Amid Long-Term Growth Challenges in Chemicals Sector",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/archit-organosys-receives-sell-upgrade-amid-weak-long-term-fundamentals-and-modest-growth-1228796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ArchitOrganosys_mojoScore_617709.png",
        "date": "2025-03-07 08:02:08",
        "description": "Archit Organosys, a microcap chemicals company, recently adjusted its evaluation based on market position and financial metrics. The firm reported a profit after tax of Rs 2.03 crore for Q3 FY24-25, but faces long-term growth challenges, reflected in its average ROCE and modest sales growth."
      },
      {
        "title": "Archit Organosys Reports Mixed Financial Results Amid Profit Recovery and Sales Decline in February 2025",
        "link": "https://www.marketsmojo.com/news/result-analysis/archit-organosys-reports-profit-after-tax-of-rs-2-03-crore-for-december-2024-1040704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/ArchitOrganosys_quaterlyResult_451556.png",
        "date": "2025-02-17 11:13:36",
        "description": "Archit Organosys has announced its financial results for the quarter ending December 2024, revealing a significant increase in Profit After Tax (PAT) to Rs 2.03 crore, compared to Rs 0.06 crore last year. However, net sales declined to Rs 25.87 crore, indicating challenges in sales performance."
      },
      {
        "title": "Archit Organosys Faces Ongoing Challenges Amidst Significant Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/archit-organosys-stock-hits-52-week-low-amid-ongoing-decline-in-performance-1041302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/ArchitOrganosys_priceRelatedfactors_452032.png",
        "date": "2025-02-17 10:06:24",
        "description": "Archit Organosys, a microcap in the chemicals sector, is nearing its 52-week low, trading slightly above it. The stock has declined 6.01% over the past two days and has underperformed over the past year, contrasting with the Sensex's gains, indicating ongoing market challenges."
      }
    ],
    "total": 19,
    "sid": "849091",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/archit-organosys-849091"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "03-Apr-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Archana Kandarp Amin & PACs",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "01-Apr-2025",
      "details": "As Attached",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "07-Mar-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kandarp Krishnakant Amin & PACs",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Archit Organosys Ltd has declared <strong>5%</strong> dividend, ex-date: 08 Aug 23",
          "dt": "2023-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Archit Organosys Ltd has announced <strong>2:1</strong> rights issue, ex-date: 09 Feb 17",
          "dt": "2017-02-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Archit Organosys Adjusts Valuation Amid Mixed Financial Performance and Market Dynamics

2025-04-02 08:11:59

Archit Organosys, a microcap chemicals company, has recently adjusted its evaluation, reflecting changes in financial metrics and market position. Key indicators show a high price-to-earnings ratio and a moderate sales growth rate, while technical performance presents mixed signals, indicating both challenges and opportunities in the current market landscape.

Read More

Archit Organosys Experiences Valuation Grade Change Amidst Competitive Market Dynamics

2025-03-25 08:00:47

Archit Organosys, a microcap player in the chemicals industry, has recently undergone a valuation adjustment, reflecting a shift in its financial standing. The company's current price is at 39.20, with a previous close of 40.09. Over the past year, Archit has experienced a stock return of 1.06%, contrasting with a 7.07% return from the Sensex, indicating a lag in performance relative to the broader market. Key financial metrics reveal a PE ratio of 80.44 and an EV to EBITDA ratio of 16.32, which positions the company within a competitive landscape. Notably, Archit Organosys has a low PEG ratio of 0.00, suggesting a unique valuation perspective compared to its peers. In comparison, companies like Shivalik Rasayan and Indo Amines exhibit varying valuation metrics, with Shivalik showing a PE ratio of 61.17 and Indo Amines at 16.52. Despite the recent valuation adjustment, Archit’s performance over a five-yea...

Read More

Archit Organosys Adjusts Valuation Amidst Mixed Financial Performance and Market Challenges

2025-03-18 08:07:45

Archit Organosys, a microcap chemicals company, has recently adjusted its evaluation following a positive Q3 FY24-25 performance, reporting a profit after tax of Rs 2.03 crore. However, challenges remain in long-term growth and financial strength, with modest sales growth and bearish technical indicators.

Read More

Archit Organosys Reports Profit Growth Amid Long-Term Growth Challenges in Chemicals Sector

2025-03-07 08:02:08

Archit Organosys, a microcap chemicals company, recently adjusted its evaluation based on market position and financial metrics. The firm reported a profit after tax of Rs 2.03 crore for Q3 FY24-25, but faces long-term growth challenges, reflected in its average ROCE and modest sales growth.

Read More

Archit Organosys Reports Mixed Financial Results Amid Profit Recovery and Sales Decline in February 2025

2025-02-17 11:13:36

Archit Organosys has announced its financial results for the quarter ending December 2024, revealing a significant increase in Profit After Tax (PAT) to Rs 2.03 crore, compared to Rs 0.06 crore last year. However, net sales declined to Rs 25.87 crore, indicating challenges in sales performance.

Read More

Archit Organosys Faces Ongoing Challenges Amidst Significant Market Activity

2025-02-17 10:06:24

Archit Organosys, a microcap in the chemicals sector, is nearing its 52-week low, trading slightly above it. The stock has declined 6.01% over the past two days and has underperformed over the past year, contrasting with the Sensex's gains, indicating ongoing market challenges.

Read More

View All News